Chronic obstructive pulmonary disease (COPD) affects 25 million people in the U.S. and is the fifth leading cause of death ...

The CEO of Connect Biopharma discusses the unique challenges that patients with asthma and COPD face. Pharmaceutical Executive: What drew you to Connect Biopharma?

Emphysema is a slow killer. Severe emphysema even alienates family members as the patients relegate themselves to the length of their oxygen tubing and suffer through an acquired mutism from ...

Short-course fluoroquinolone treatment is as effective as the conventional 7-day course for acute exacerbations of chronic obstructive pulmonary disease.

COPD has a large economic impact on the healthcare system and a destructive impact on the lives of patients and their ...

Chronic breathlessness, coughing or excess mucus may seem minor, but they could signal chronic obstructive pulmonary disease.

Researchers discover an unusual accumulation of particles in people with the disease; the causes are still unclear.

A COPD treatment for former smokers developed by Regeneron Pharmaceuticals and Sanofi failed to meet its primary endpoint in one Phase 3 trial.

Digital inhalers that allow remote patient monitoring may predict impending exacerbations, or episodes when symptoms of COPD ...

Australians living with chronic obstructive pulmonary disease (COPD) are being exposed to greater health risks as the use of a critical diagnostic ...

Fatigue is one of the most common symptoms of COPD, so it's important to understand what causes it, columnist Caroline Gainer says.

Yoga can be a valuable complement to pulmonary therapy for chronic respiratory diseases, such as COPD and asthma. By ...